The Market's Mysterious Meltdown

The controversial financial product known as XIV is shouldering a lot of the blame for the recent flash crash that saw the Dow slump more than 6% in a span of six minutes. Dave Mazza, Head of ETF Investment Strategy at OppenheimerFunds, was with us to break down the theory that volatility-based products fueled the market meltdown. The XIV is meant to produce the opposite returns of the volatility index, which spiked 118% Monday. Mazza explained that 2017 was a great year for stocks with record-low volatility. Due to this low volatility, many investors were feasting on these financial products, looking to benefit from volatility going lower. When the exact opposite happened, those investors dealt with the consequences. "A lot of people like to point the finger at computerized trading for sharp movements in stocks," said Mazza. He said it's only one piece of the story. Mazza highlighted that fundamentals are important to watch and there are many variables that influence stock movement.

More In Business

The Economic ‘Pain’ Fed Chief Jerome Powell Warned About Is Here

Data shows the economy grew less than expected in the first three months of the year, as consumers became more price conscious and spent less.

Will Live Nation and Ticketmaster Actually Be Broken Up?

The CEO of LiveOne, Rob Ellin, discusses the DOJ's lawsuit against Live Nation and Ticketmaster, how will if affect you and the future of live events. Watch!

The Future of Ether ETFs After That SEC Ruling

CoinShares CEO, Jean-Marie Mognetti, joins Cheddar to discuss what's next for ether ETFs and other cryptocurrency after the SEC surprise ruling.

The Trending, Fastest-Growing Summer Destinations Will Surprise You

From the Vegas strip to breathtaking national parks, we’re obsessed.

Nvidia's Blockbuster Run Is Just Getting Started

Nvidia did a record $26 billion in sales in the latest quarter. And get ready for the stock to keep climbing, because the A.I. boom is just getting started.

Perspective Therapeutics Is Creating New Ways to Fight Cancer

In honor of National Cancer Research Month, Perspective Therapeutics discusses its latest treatment — currently in clinical trials — that targets cancer cells d

When It Comes to the Economy, There’s ‘A Lot to Be Optimistic About’

Business is booming, interest rate cuts aren’t desperately needed, and, consumers are in what one analyst calls ‘pretty good shape.’

More People Are Making 'no-buy year' Pledges. Should You?

The self-imposed rules of a no-buy challenge are simple: participants pledge to stop buying non-essential items.

Forget Inflation: American Consumers Want Travel and Experiences

Americans may be exhausted by inflation, but they aren't holding back when to comes to spending on travel and experiences.

The U.S. Can Avoid a Recession – But Higher Prices Are Here to Stay

Companies like Target, Walmart, and Amazon may be cutting prices – but consumers should get used to paying more than they did pre-pandemic.

Load More